Advanced company searchLink opens in new window

INTERCEPT PHARMA EUROPE LTD.

Company number 09224395

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Jul 2022 CH01 Director's details changed for Linda Richardson on 26 July 2022
26 Jul 2022 PSC05 Change of details for Intercept Pharmaceuticals, Inc. as a person with significant control on 26 July 2022
26 Jul 2022 CH01 Director's details changed for Rocco Venezia on 26 July 2022
26 Jul 2022 TM01 Termination of appointment of Willem Wouter Van Weperen as a director on 1 July 2022
26 Jul 2022 TM01 Termination of appointment of Olufemi Abimbola Adekunle as a director on 1 July 2022
29 Dec 2021 SH01 Statement of capital following an allotment of shares on 27 December 2021
  • GBP 251
11 Nov 2021 AA Full accounts made up to 31 December 2020
01 Nov 2021 TM01 Termination of appointment of Caroline Stockwell as a director on 29 October 2021
19 Oct 2021 AP01 Appointment of Dr Olufemi Abimbola Adekunle as a director on 19 October 2021
14 Oct 2021 SH01 Statement of capital following an allotment of shares on 7 October 2021
  • GBP 247
11 Oct 2021 CH01 Director's details changed for Willem Wouter Van Weperen on 10 October 2021
01 Oct 2021 CS01 Confirmation statement made on 30 September 2021 with updates
02 Jul 2021 SH01 Statement of capital following an allotment of shares on 28 June 2021
  • GBP 241
02 Jul 2021 AP01 Appointment of Willem Wouter Van Weperen as a director on 28 June 2021
02 Jul 2021 AP01 Appointment of Linda Richardson as a director on 28 June 2021
02 Jul 2021 AP01 Appointment of Mr Michael Gemellaro as a director on 28 June 2021
26 Mar 2021 TM01 Termination of appointment of Sandip Kapadia as a director on 26 March 2021
23 Mar 2021 AP01 Appointment of Rocco Venezia as a director on 17 March 2021
22 Mar 2021 SH01 Statement of capital following an allotment of shares on 8 March 2021
  • GBP 233
03 Mar 2021 TM01 Termination of appointment of Stephen Arnold as a director on 26 February 2021
08 Jan 2021 TM01 Termination of appointment of Mark Pruzanski as a director on 1 January 2021
07 Jan 2021 TM01 Termination of appointment of Robert James Carey as a director on 7 January 2021
06 Jan 2021 SH01 Statement of capital following an allotment of shares on 9 December 2020
  • GBP 225
06 Jan 2021 AP01 Appointment of Caroline Stockwell as a director on 9 December 2020
05 Jan 2021 AA Full accounts made up to 31 December 2019